TORONTO, ONTARIO and MISSISSAUGA, ONTARIO -- (Marketwire) -- 02/06/13 -- Canada's largest and most established stem cell bank is the newest member of the Centre for Commercialization of Regenerative Medicine's (CCRM) industry consortium (IC). Insception Lifebank Cord Blood Program, a FACT-accredited family cord blood bank, has extensive experience working with hematopoietic (blood) stem cells that CCRM will soon require to advance its therapeutic product pipeline.
"Insception Lifebank is a Canadian success story and its membership in the IC helps us check some of those final boxes in the expertise that we seek from our business partners," says Dr. Michael May, CEO of CCRM. "Insception Lifebank offers tremendous knowledge in clinical applications of hematopoietic stem cells (HSCs), and sharing that knowledge is valuable for other IC members, CCRM and the academic community; and, ultimately, we intend to commercialize novel HSC technologies for patients."
"We are pleased to be part of this outstanding group. This alliance supports our commitment to research and advancing stem cell use," says Richard L. Lockie, President & CEO of Insception Biosciences Inc. "Our mission is to provide the best possible stem cells from the umbilical cord blood to healthcare professionals to advance their effectiveness in transplantation and cellular therapy."
CCRM's 20 plus industry consortium members represent the key sectors of the industry: therapeutics, devices, reagents, and cells as tools. CCRM has built three core development platforms: cell reprogramming and engineering; cell manufacturing; and, biomaterials and devices to carry out projects commissioned by academia and industry. CCRM has a fully resourced, 6,000 square foot development facility where all development work takes place.
Please visit http://www.ccrm.ca/industry-consortium to see a complete list of CCRM's members.
About the Centre for Commercialization of Regenerative Medicine (CCRM)
CCRM, a Canadian not-for-profit organization funded by the Government of Canada's Networks of Centres of Excellence program and six academic partners, supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. A network of academics, industry and entrepreneurs, CCRM aims to translate scientific discoveries into marketable products for patients. CCRM launched in Toronto's Discovery District on June 14, 2011. CCRM is hosted by the University of Toronto.
About Insception Lifebank
Insception Lifebank, is the largest and most experienced national FACT-accredited cord blood bank in Canada. Insception is a private company owned by Argosy Partners, Mount Sinai Hospital, management and its scientific founders. By continuing to partner with leading Canadian hospitals such as Toronto's Mount Sinai and Scarborough Hospitals, the Insception Lifebank Cord Blood Program is able to provide every Canadian family with security, state-of-the-art processing and storage, financial stability and long-term professional governance. For more information, visit www.insception.com.
Centre for Commercialization of Regenerative Medicine
Insception Lifebank Cord Blood Program
VP, Sales and Marketing
Most Popular Stories
- Tablets, Cars Drive AT&T Gains
- 2015 Mazda MX-5 Miata Is Fast and Eager
- Small Businesses Add 3 More Worries to Their List
- DOMA Tech Adding Jobs to Process VA Claims
- Apple Warns of China iCloud Attack
- Job Hunting Is Hard Work
- Tech Firms Flock to LA's 'Silicon Beach'
- Stocks Subdued After Gains Earlier in Week
- Ford, GM Expect to Report Strong Profits
- Consumer Prices Edge Up, Surprising Economists